
Please try another search
Vascular Biogenics Ltd, former Medicard Ltd, is Israel- based clinical stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. It's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
Name | Age | Since | Title |
---|---|---|---|
Dror Harats | 64 | 2000 | CEO & Director |
Marc D. Kozin | 61 | 2020 | Independent Non-Executive Chairman |
Nicholas A. Butowski | - | - | Member of Scientific Advisory Board |
Bradley J. Monk | - | - | Member of Scientific Advisory Board |
Kathleen Moore | - | - | Member of Scientific Advisory Board |
Ruth Arnon | 89 | 2007 | Scientific Consultant & Member of Scientific Advisory Board |
Shmuel Ben-Zvi | 62 | 2018 | Independent Non-Executive Director |
Patrick Yung Wen | - | - | Member of Scientific Advisory Board |
Thomas Herzog | - | - | Member of Scientific Advisory Board |
Antonio Casado Herraez | - | - | Member of Scientific Advisory Board |
Ruth Alon | 70 | 2010 | Independent Non-Executive Director |
Krishnansu S. Tewari | - | 2020 | Member of Scientific Advisory Board |
Richard T. Penson | - | - | Member of Scientific Advisory Board |
Andrew J. Brenner | - | - | Member of Scientific Advisory Board |
Ronnie Shapira-Frommer | - | 2019 | Member of Scientific Advisory Board |
Michael Yehuda Rice | 57 | 2021 | Independent Non-Executive Director |
Timothy Cloughesy | - | - | Member of Scientific Advisory Board |
David C. Hastings | 61 | 2018 | Independent Non-Executive Director |
Rebecca C. Arend | - | - | Member of Scientific Advisory Board |
Jonathan A. Ledermann | - | 2020 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review